Literature DB >> 12531618

Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

Roland Fischer, Rainer Engelhardt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12531618     DOI： 10.1016/S0140-6736(03)12222-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

2.  MRI detects myocardial iron in the human heart.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Ignacio Gonzalez; Marvin D Nelson; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

3.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

4.  Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia.

Authors:  Zhiyue J Wang; Roland Fischer; Zili Chu; Donald H Mahoney; Brigitta U Mueller; Raja Muthupillai; Ellen B James; Rajesh Krishnamurthy; Taylor Chung; Eric Padua; Elliott Vichinsky; Paul Harmatz
Journal:  Magn Reson Imaging       Date:  2010-01-12       Impact factor: 2.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.